BioMarin, a leading biotechnology company, has announced a significant expansion of its manufacturing plant in Cork, Ireland. The €38m investment will create 40 new jobs, adding to the 400 already employed at the site. This expansion marks a significant milestone for BioMarin in Ireland as it continues to grow its presence in the region. The creation of these new jobs will bring a welcome boost to the Cork area and cement Ireland’s position as a hub for biopharmaceutical innovation.
BioMarin Pharmaceutical Inc., a global biopharmaceutical company, has unveiled the expansion of its manufacturing plant located in Shanbally, Cork. The state-of-the-art aseptic production facility was built with a four-year investment of €38 million and will be used to manufacture, package and label BioMarin therapies for global distribution. The expansion will enable BioMarin to begin end-to-end manufacturing for commercial products as well as gene therapies, thereby increasing the company’s pipeline. Michael Lohan, CEO of IDA Ireland, acknowledges BioMarin’s investment in Ireland, which positions the country as a global leader in the manufacturing of treatments for rare diseases. BioMarin is currently hiring over 40 employees across its Shanbally site.
As BioMarin’s Cork plant expands, it’s clear that there will be exciting new job opportunities for the area. With a €38m investment, BioMarin is paving the way for the development and advancement of the biotechnology industry in Ireland.
These 40 new jobs represent a significant win for both BioMarin and the Irish economy as a whole. They will bring highly skilled employment opportunities to the local community, supporting economic growth and driving innovation.
With a focus on gene therapy and rare diseases, BioMarin is at the forefront of cutting-edge medical technology. This expansion will undoubtedly have a positive impact on the health and well-being of people across the world.
Overall, the expansion of the Cork plant is a testament to BioMarin’s commitment to innovation, to Ireland’s forward-thinking approach to biotechnology, and to the exciting possibilities that lie ahead in the field of biotech. We look forward to seeing what the future holds for BioMarin and the Irish biotech industry.
